- In April 2025, a study presented at the Academy of Managed Care Pharmacy (AMCP) 2025 conference highlighted an AI-powered platform that significantly improves polypharmacy risk management. The system helped detect 80% more high-risk patients, resulting in a 6% reduction in hospitalization rates and a 2.6-fold drop in emergency visits. This development underscores the growing impact of AI in optimizing drug regimens and improving healthcare outcomes for polypharmacy patients Source
- In February 2025, Pharmacy Times reported increasing integration of AI-driven clinical decision support tools across pharmacy workflows to reduce adverse drug events and streamline medication reviews. These tools are being widely adopted in high-risk populations such as elderly patients and palliative care settings, where polypharmacy is most prevalent. The technology aids in deprescribing and enhances precision in pharmacological interventions Source
